Related Experiment Video
Updated: Aug 22, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
[Eligibility criteria for surgery for drug-resistant partial epilepsy in adults]
1EFSN, Département de Neurologie, CHU Grenoble, BP 217X-38043 Grenoble Cedex, France. LVercueil@chu-grenoble.fr
Abstract:
Eligibility criteria for surgical treatment in drug-resistant partial epilepsy are defined by the clinical and laboratory elements which favored the initiation of often costly and sometimes invasive investigations performed to determine the patient's operability. These criteria, which require a multidisciplinary team including a neurosurgeon, a neurophysiologist and a neurologist, must be distinguished from the operability criteria used by expert centers. Theoretically, eligibility criteria must be validated in terms of both sensitivity (capability to detect good candidates for surgery among the epileptic population) and specificity (exclusion of false candidates). Up to now, such validation of eligibility criteria has been lacking. The present systematic literature review examines the criteria currently used in controlled and multicentric studies, and the criteria which proved to be useful in determining outcome. This last set of criteria is theoretically a good candidate for future validation studies.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
